Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04620382
EARLY_PHASE1

Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients

Sponsor: Vanderbilt University Medical Center

View on ClinicalTrials.gov

Summary

The purpose of this study is to learn more about the effects of abdominal compression and the medication midodrine, two interventions used for the treatment of orthostatic hypotension (low blood pressure on standing), on hemodynamic markers of cardiovascular risk. The study will be conducted at the Vanderbilt University Medical Center and consists of a screening and 2 testing days, one with abdominal compression and one with midodrine. The total length of the study will be about 5 days.

Key Details

Gender

All

Age Range

40 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

31

Start Date

2020-11-09

Completion Date

2026-12-01

Last Updated

2026-01-12

Healthy Volunteers

No

Interventions

DRUG

Midodrine

Midodrine 5-10 mg, single oral dose

DRUG

Placebo pill

single oral dose

DEVICE

Abdominal compression

abdominal compression up to 40 mmHg during head-up tilt

DEVICE

sham compression

Sham abdominal compression during head-up tilt

Locations (1)

Vanderbilt University Medical Center

Nashville, Tennessee, United States